Autolus Therapeutics plc (FRA:6A3A)
Germany · Delayed Price · Currency is EUR 1.350
-0.080 (-5.59%)
Last updated: Oct 23, 2026, 3:49 PM CEST
Autolus Therapeutics Market Cap
Autolus Therapeutics has a market cap or net worth of €366.03 million as of October 26, 2026. Its market cap has increased by 3.03% in one year.
Market Cap
366.03M
Enterprise Value
514.43M
Revenue
102.75M
Global Rank
n/a
Country Rank
n/a
PE Ratio
n/a
ChartMarket Cap Chart
Since June 22, 2018, Autolus Therapeutics's market cap has decreased from 833.42M to 366.03M, a decrease of -56.08%. That is a compound annual growth rate of -9.39%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 366.03M | -18.85% |
| Dec 31, 2025 | 451.08M | -25.33% |
| Dec 31, 2024 | 604.06M | -40.39% |
| Dec 29, 2023 | 1.01B | 229.38% |
| Dec 30, 2022 | 307.67M | -7.54% |
| Dec 31, 2021 | 332.77M | -12.94% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jun 22, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Merck KGaA | 62.30B |
| Siemens Healthineers AG | 46.59B |
| Bayer Aktiengesellschaft | 43.21B |
| Fresenius SE & Co. KGaA | 25.97B |
| Eckert & Ziegler SE | 817.88M |
| Evotec SE | 499.48M |
| M1 Kliniken AG | 359.60M |
| Formycon AG | 332.96M |